This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3c08

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3c08.png|left|200px]]
 
- 
{{STRUCTURE_3c08| PDB=3c08 | SCENE= }}
{{STRUCTURE_3c08| PDB=3c08 | SCENE= }}
- 
===Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)===
===Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)===
- 
{{ABSTRACT_PUBMED_18394559}}
{{ABSTRACT_PUBMED_18394559}}
Line 14: Line 10:
==Reference==
==Reference==
-
<ref group="xtra">PMID:018394559</ref><references group="xtra"/>
+
<ref group="xtra">PMID:018394559</ref><references group="xtra"/><references/>
[[Category: Mus musculus]]
[[Category: Mus musculus]]
[[Category: Ferguson, K M.]]
[[Category: Ferguson, K M.]]

Revision as of 12:19, 24 March 2013

Template:STRUCTURE 3c08

Contents

Crystal structure the Fab fragment of matuzumab/EMD72000 (Fab72000)

Template:ABSTRACT PUBMED 18394559

About this Structure

3c08 is a 2 chain structure with sequence from Mus musculus. Full crystallographic information is available from OCA.

See Also

Reference

  • Schmiedel J, Blaukat A, Li S, Knochel T, Ferguson KM. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell. 2008 Apr;13(4):365-73. PMID:18394559 doi:10.1016/j.ccr.2008.02.019

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools